BGLC$0.95-5.43%
BioNexus Gene Lab Corp
Sector: Services-Medical LaboratoriesIndustry: Industrial - DistributionCountry: MYExchange: Nasdaq
Mkt Cap:$2.79M
Float & O/S:
Inst Own:
DilutionScan read 21 of BioNexus Gene Lab Corp's SEC filings and found 1 warrant series, 1 ATM program, 1 equity line, 1 shelf registration, 1 S-1 registration and 3 completed offerings on file for BGLC. The latest dilution event on file is ATM sales on Aug 14, 2026. Analysis updated Oct 21, 2026.